W E Schmidt
Overview
Explore the profile of W E Schmidt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
191
Citations
2324
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gambichler T, Reuther J, Stucker M, Stranzenbach R, Torres-Reyes C, Schlottmann R, et al.
J Eur Acad Dermatol Venereol
. 2020 Oct;
35(3):e187-e189.
PMID: 33002210
No abstract available.
2.
Schultheis B, Reuter D, Ebert M, Siveke J, Kerkhoff A, Berdel W, et al.
Ann Oncol
. 2017 Sep;
28(10):2429-2435.
PMID: 28961832
Background: This randomized study was designed to investigate the superiority of gemcitabine (gem) plus nimotuzumab (nimo), an anti-epidermal growth factor receptor monoclonal antibody, compared with gem plus placebo as first-line...
3.
Breuer T, Kampmann K, Wutzler A, Steinfort C, Uhl W, Schmidt W, et al.
Internist (Berl)
. 2017 Sep;
59(3):282-287.
PMID: 28864828
Two female patients were admitted due to ketoacidosis. Serum glucose was moderately elevated. The patients exhibited abdominal and neurologic symptoms. Treatment consisted of metformin, insulin glargin and empagliflozin, as well...
4.
Breuer T, Breuer H, Menge B, Giese A, Uhl W, Schmidt W, et al.
Internist (Berl)
. 2016 Feb;
57(4):385-9.
PMID: 26873007
A 64-year-old woman presented with a history of recurrent hypoglycemia. A prolonged fasting test revealed an increased "amended" insulin-glucose ratio. Transabdominal ultrasound (US), computed tomography (CT) scan, and magnetic resonance...
5.
Fensterer H, Schade-Brittinger C, Muller H, Tebbe S, Fass J, Lindig U, et al.
Ann Oncol
. 2013 Jul;
24(10):2576-2581.
PMID: 23897705
Background: To investigate whether addition of cetuximab to standard adjuvant chemotherapy with gemcitabine improves outcome in pancreatic cancer, specifically whether the rate of disease-free survival (DFS) at 18 months (primary...
6.
Meier J, Pennartz C, Schenker N, Menge B, Schmidt W, Heise T, et al.
Diabetes Obes Metab
. 2012 Oct;
15(3):258-63.
PMID: 23039360
Aim: Postprandial insulin pulsatility is impaired in patients with type 2 diabetes, but the effects of exogenous insulin therapy on pulsatile insulin secretion are not known. We addressed, whether pulsatile...
7.
Meier J, Breuer T, Bonadonna R, Tannapfel A, Uhl W, Schmidt W, et al.
Diabetologia
. 2012 Jan;
55(5):1346-54.
PMID: 22286529
Aims/hypothesis: Diabetes frequently develops in patients with pancreatic disorders. We aimed to determine the lower threshold of beta cell area for diabetes manifestation as well as the impact of insulin...
8.
Pennartz C, Schrader H, Ritter P, Tannapfel A, Schmidt W, Meier J
Internist (Berl)
. 2011 Nov;
53(1):88-92.
PMID: 22119907
Although liver damage is a relatively rare adverse effect of oral anticoagulation with phenprocoumon, acute liver failure can be a serious treatment-associated complication. In this contribution, a patient with drug-induced...
9.
Lohr J, Haas S, Bechstein W, Bodoky G, Cwiertka K, Fischbach W, et al.
Ann Oncol
. 2011 Sep;
23(5):1214-1222.
PMID: 21896540
Background: Paclitaxel embedded in cationic liposomes (EndoTAG™-1; ET) is an innovative agent targeting tumor endothelial cells. This randomized controlled phase II trial evaluated the safety and efficacy of ET in...
10.
Zinman B, Schmidt W, Moses A, Lund N, Gough S
Diabetes Obes Metab
. 2011 Sep;
14(1):77-82.
PMID: 21883806
Aim: Effective type 2 diabetes management requires a multifactorial approach extending beyond glycaemic control. Clinical practice guidelines suggest targets for HbA1c, blood pressure and lipids, and emphasize weight reduction and...